Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free
Intercept Pharmaceuticals NASDAQ ICPT
- - -%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 20 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

-
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
282.16M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.43
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
41.79M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-
Upcoming events Intercept Pharmaceuticals All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart Intercept Pharmaceuticals

Stock analysis Intercept Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
- 13.17
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
- 4.20
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-4.56 9.25
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-4.56 -0.09
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-81.58 9.25

Price change Intercept Pharmaceuticals per year

11.60$ 40.41$
Min Max

Summary analysis Intercept Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Intercept Pharmaceuticals

Revenue and net income Intercept Pharmaceuticals

All parameters
Stock news Intercept Pharmaceuticals All news
26 September 2023 в 15:16

Intercept Pharmaceuticals’ stock set to soar after Alfasigma buyout deal for an 82% premium

22 May 2023 в 14:45

Intercept Pharmaceuticals stock tumbles toward 11-month low after disappointing FDA committee vote

17 May 2023 в 00:50

Intercept Pharmaceuticals Gets Orphan Drug Status for OCA and Bezafibrate to Treat Primary Biliary Cholangitis

17 May 2023 в 00:45

Intercept Pharmaceuticals Gets Orphan Drug Status for OCA and Bezafibrate to Treat Primary Biliary Cholangitis

23 December 2022 в 16:20

Intercept Pharmaceuticals Resubmits New Drug Application for Obeticholic Acid

23 December 2022 в 16:20

Intercept Pharmaceuticals Resubmits New Drug Application for Obeticholic Acid

30 September 2022 в 18:02

Intercept Pharmaceuticals Shares Slide After NASH Study Miss >ICPT

30 September 2022 в 18:02

Intercept Pharmaceuticals Shares Slide After NASH Study Miss >ICPT

21 September 2022 в 19:40

Intercept Pharmaceuticals Shares Tumble 17% Following Financial Repositioning

21 September 2022 в 19:36

Intercept Pharmaceuticals Shares Tumble 17% Following Financial Repositioning

2 September 2022 в 15:21

Intercept Pharmaceuticals Retires Additional Senior Notes

2 September 2022 в 15:20

Intercept Pharmaceuticals Retires Additional Senior Notes

3 August 2022 в 18:45

Intercept Pharmaceuticals Shares Up 14% Following Better-Than-Expected Earnings

3 August 2022 в 18:40

Intercept Pharmaceuticals Shares Up 14% Following Better-Than-Expected Earnings

3 August 2021 в 19:24

Intercept Pharmaceuticals stock price target cut to $31 from $43 at Canaccord Genuity

About company Intercept Pharmaceuticals

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. Its lead products candidate is the Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid in adults. The company is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis (NASH); and other product candidates in various stages of clinical and preclinical development. It has a license agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. The company markets its products through an internal commercial organization, a contract sales organization, and third-party distributors. Intercept Pharmaceuticals, Inc. was incorporated in 2002 and is headquartered in New York, New York.
Address:
10 Hudson Yards, New York, NY, United States, 10001
Company name: Intercept Pharmaceuticals
Issuer ticker: ICPT
ISIN: US45845P1084
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2012-10-11
Sector: Healthcare
Industry: Biotechnology
Site: https://www.interceptpharma.com

On which stock exchange are Intercept Pharmaceuticals (ICPT) stocks traded?

Intercept Pharmaceuticals (ICPT) stocks are traded on NASDAQ.

What is the ticker of Intercept Pharmaceuticals stocks (ICPT)?

The stock ticker of Intercept Pharmaceuticals’s stocks or in other words, the code is ICPT. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Intercept Pharmaceuticals (ICPT) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Intercept Pharmaceuticals (ICPT) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Intercept Pharmaceuticals (ICPT) stocks traded?

Intercept Pharmaceuticals (ICPT) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Intercept Pharmaceuticals (ICPT) stocks today?

The current price of Intercept Pharmaceuticals stocks on 29.04.2024 is dollars. per share.

What is the dynamics of Intercept Pharmaceuticals (ICPT) stocks from the beginning of the year?

Intercept Pharmaceuticals (ICPT) quotes have increased by 0% from the beginning of the year up to dollars. per 1 stocks.

How much did Intercept Pharmaceuticals (ICPT) stocks increase in апреле 2024?

This month Intercept Pharmaceuticals (ICPT) quotes have increased by 0% to dollars. per share.

How much are Intercept Pharmaceuticals (ICPT) stocks worth?

Today, on October, 29.04.2024 Intercept Pharmaceuticals’s (ICPT) stocks cost dollars..

What is the market capitalization of Intercept Pharmaceuticals (ICPT)?

Capitalization is the market value of Intercept Pharmaceuticals (ICPT) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 29.04.2024, the market capitalization of Intercept Pharmaceuticals (ICPT) is estimated at about 0 dollars.